Search

  • HOME
  • Search
Review
1738
Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol. 2023;29(Suppl):S184-S195.   Published online December 5, 2022
View: 4409   Download: 190  Web of Science: 11  Crossref: 13
Snapshot
1689
Personalized medicine in nonalcoholic fatty liver disease
Carlos J. Pirola, Silvia Sookoian
Clin Mol Hepatol. 2022;28(4):935-938.   Published online June 24, 2022
View: 4767   Download: 147  Web of Science: 7  Crossref: 6
Editorial
1701
Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait
Carlos J. Pirola, Silvia Sookoian
Clin Mol Hepatol. 2022;28(4):806-809.   Published online August 19, 2022
View: 2760   Download: 72
Review
1531
Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol. 2020;26(4):461-475.   Published online September 10, 2020
View: 9014   Download: 289  Web of Science: 40  Crossref: 40
1338
Genetic predisposition in nonalcoholic fatty liver disease
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol. 2017;23(1):1-12.   Published online March 9, 2017
View: 18546   Download: 611  Web of Science: 153  Crossref: 153
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 526
TOTAL : 2102125
Close layer